We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+29%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.1B
AUM Growth
+$1.94B
Cap. Flow
-$956M
Cap. Flow %
-6.31%
Top 10 Hldgs %
19.25%
Holding
1,647
New
467
Increased
323
Reduced
312
Closed
527

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$208M
2
JNJ icon
Johnson & Johnson
JNJ
+$190M
3
PFE icon
Pfizer
PFE
+$166M
4
NVDA icon
NVIDIA
NVDA
+$154M
5
ADBE icon
Adobe
ADBE
+$134M

Sector Composition

Rank Sector Weight
1 Healthcare 27.79%
2 Technology 18.34%
3 Consumer Discretionary 12.92%
4 Financials 8.19%
5 Industrials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CROX icon
251
Crocs
CROX
$6.55B
$11.6M 0.08%
313,840
-64,065
-17% -$1.7M
DAY
252
DELISTED
Dayforce
DAY
$11.4M 0.08%
+144,232
New +$9.26M
ZNGA
253
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$11.3M 0.07%
1,179,277
-1,990,656
-63% -$16.3M
OBDC icon
254
Blue Owl Capital
OBDC
$5.74B
$11M 0.07%
892,553
+100,289
+13% +$1.24M
AVB icon
255
AvalonBay Communities
AVB
$26.8B
$10.9M 0.07%
70,514
+64,371
+1,048% +$10.2M
TEAM icon
256
Atlassian
TEAM
$37.8B
$10.7M 0.07%
59,280
-41,107
-41% -$6.83M
AES icon
257
AES
AES
$10.5B
$10.7M 0.07%
736,233
+572,580
+350% +$7.52M
AGNC icon
258
AGNC Investment
AGNC
$12.9B
$10.6M 0.07%
821,960
+802,220
+4,064% +$10.1M
ZYME icon
259
Zymeworks
ZYME
$1.67B
$10.5M 0.07%
290,524
-8,300
-3% -$306K
LW icon
260
Lamb Weston
LW
$7.19B
$10.5M 0.07%
163,728
-312,973
-66% -$18.9M
CTAS icon
261
Cintas
CTAS
$81.3B
$10.4M 0.07%
156,896
+134,732
+608% +$7.79M
MRK icon
262
Merck
MRK
$318B
$10.4M 0.07%
141,572
-2,765,823
-95% -$208M
XLRN
263
DELISTED
Acceleron Pharma
XLRN
$10.3M 0.07%
108,294
+103,349
+2,090% +$9.96M
JAZZ icon
264
Jazz Pharmaceuticals
JAZZ
$16.7B
$10.3M 0.07%
+93,186
New +$10.3M
VMC icon
265
Vulcan Materials
VMC
$36.9B
$10M 0.07%
86,316
-117,448
-58% -$12.9M
HLNE icon
266
Hamilton Lane
HLNE
$5.57B
$9.84M 0.07%
+146,050
New +$9.2M
NLY icon
267
Annaly Capital Management
NLY
$17.4B
$9.83M 0.06%
374,559
+351,416
+1,518% +$8.68M
MCO icon
268
Moody's
MCO
$82.7B
$9.77M 0.06%
35,560
+20,438
+135% +$5.19M
ENB icon
269
Enbridge
ENB
$112B
$9.74M 0.06%
321,233
+183,011
+132% +$5.62M
SCHW
270
Charles Schwab
SCHW
$187B
$9.71M 0.06%
+287,697
New +$10.3M
VVV icon
271
Valvoline
VVV
$4.51B
$9.67M 0.06%
500,197
-635,643
-56% -$10.8M
AKAM icon
272
Akamai
AKAM
$15.9B
$9.63M 0.06%
89,912
-209,718
-70% -$21.1M
BLKB icon
273
Blackbaud
BLKB
$2.08B
$9.58M 0.06%
167,876
+108,913
+185% +$5.99M
ORLY icon
274
O'Reilly Automotive
ORLY
$76.3B
$9.46M 0.06%
+336,555
New +$8.8M
EQR icon
275
Equity Residential
EQR
$25.1B
$9.31M 0.06%
+158,366
New +$9.81M

Similar funds

Marshall Wace North America's Q2 2020 Portfolio in Review

As of Q2 2020, Marshall Wace North America held 1,647 positions worth $15.1B, up 15% from $13.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America withdrew a net $956M in Q2 2020, closing 527 positions and reducing 312 holdings. Its most notable exit was Becton Dickinson, an estimated $86.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Motorola Solutions worth $88.4M.

  • Marshall Wace North America's largest Q2 2020 buy was Motorola Solutions: 630,587 shares worth $88.4M.
  • Marshall Wace North America added most to JPMorgan Chase in Q2 2020, an estimated $148M increase.
  • Marshall Wace North America's biggest Q2 2020 reduction was Merck, cutting an estimated $208M.
  • Marshall Wace North America fully exited Becton Dickinson in Q2 2020, selling an estimated $86.4M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $15.1B portfolio in Q2 2020.
  • Marshall Wace North America opened 467 new positions and closed 527 in Q2 2020.
  • Marshall Wace North America's portfolio value rose 15% quarter-over-quarter to $15.1B.

Based on Marshall Wace North America's 13F filing for Q2 2020, filed 13 Aug 2020.